Search

everythinglearnresearchcommunity

for

Search:↓

Light diffraction helps in eye surgery, brain treatments, and detecting hair loss and genetic diseases.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Flutamide and its metabolite can effectively reduce androgen effects.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Eclipta alba extract could be a promising natural treatment for hair loss.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Male pattern baldness does not cause an increased risk of prostate cancer.

Men with baldness on the top of their head might have a small increased risk of prostate cancer.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.